Dana Brown
Dana Brown is co-director of theory, research, and policy at The Democracy Collaborative and is director of The Next System Project at the Collaborative.
Articles by this author
 |
Views Friday, October 09, 2020 Primary Health Care Is in Critical Condition. Making Primary Care Public Will Restore Its Health—and Protect Ours The strain that the COVID-19 pandemic is placing on our entire healthcare system is threatening to decimate the primary care sector—the doctor’s offices and medical facilities that are the very foundation of any healthcare system. Just when Americans most need consistent and equitable access to... Read more |
 |
Views Wednesday, August 26, 2020 It's Time to Take on Big Pharma and Reclaim Medicines for Public Health: We Need A Public Option in Pharmaceuticals America, we have a drug problem, and it’s worse than you might realize. Deep into our third (yes, third ) profit-motivated opioid epidemic, we are now also facing a global pandemic without the treatments and vaccines we need to prevent further mass death. At the same time, ordinary Americans who... Read more |
 |
Views Thursday, August 20, 2020 Reclaim Public Medicine for Public Health Far too many people have suffered and died because our medicines and medical products system was not prepared to respond to the COVID-19 pandemic with prompt and universal access to reliable tests, treatments, and vaccines. Governments, non-profits, and industry in the U.S. and around the world are... Read more |
 |
Views Friday, September 20, 2019 Pelosi Plan Not Good Enough: Lower Drug Prices Now Through a Pharmaceutical Public Option House Speaker Nancy Pelosi on September 19 released the “Lower Drug Costs Now Act” (H.R. 3), which would institute a series of measures designed to address runaway prescription drug costs. For people forced to struggle financially and medically as a result of the predatory behavior of Big Pharma,... Read more |
 |
Views Thursday, December 20, 2018 At Last, a Good First Step Toward Public Pharmaceuticals Public production of essential medicines is an idea whose time has come. Broad-based support for taking this step has been growing, and on Tuesday, Sen. Elizabeth Warren and Rep. Jan Schakowsky introduced a bill that would create the public Office of Drug Manufacturing ( ODM ) to do just that. The... Read more |
 |
Views Tuesday, October 09, 2018 A Nobel Prize-Winning Cancer Therapy Will Be Unaffordable for Most Americans. Public Pharmaceuticals Can Help Change That. Last week, researchers James Allison and Tasuku Honjo were awarded this year's Nobel Prize in medicine for their work on cancer immunotherapies, heralded by the Nobel committee as "seminal discoveries" that "constitute a landmark in our fight against cancer." Immunotherapies like those developed on... Read more |
|
Views Wednesday, March 19, 2014 55 Years Is Enough: Lift the Cuba Embargo Dressed in a blazer, sweater, and gloves to protect him from the cold of a DC winter, petite 79-year old Reverend Raul Suarez loves to tell his story. Read more |
|
|
Views Wednesday, November 28, 2012 Colombian Prosecutor Charging Human Rights Defender is Implicated in Forced Disappearance After years of enduring threats from paramilitary organizations, David Ravelo, a Colombian human rights defender, economist and founding member of the Regional Corporation for the Defense of Human Rights (CREDHOS), has been imprisoned for the last two years based on the testimony of demobilized paramilitaries. The circumstances surrounding the case against him are filled with irregularities, including accusations of witness tampering and serious questions about witness credibility. Read more |